Luís Teixeira

8.5k total citations · 1 hit paper
93 papers, 3.3k citations indexed

About

Luís Teixeira is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luís Teixeira has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 25 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luís Teixeira's work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (11 papers) and Medical Imaging Techniques and Applications (10 papers). Luís Teixeira is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (11 papers) and Medical Imaging Techniques and Applications (10 papers). Luís Teixeira collaborates with scholars based in France, United States and Spain. Luís Teixeira's co-authors include Loı̈c Guillevin, Josep Tabernero, Catherine Dodé, Brian Lu, Daniel D. Von Hoff, Salvatore Siena, Jean‐Luc Van Laethem, A. Bérezné, Christophe Tournigand and Alfredo Romano and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Luís Teixeira

87 papers receiving 3.2k citations

Hit Papers

nab-Paclitaxel Plus Gemci... 2015 2026 2018 2022 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
    2015 504 citations David Goldstein, Robert H. El-Maraghi et al. JNCI Journal of the National Cancer Institute profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Luís Teixeira 1.1k 698 604 585 526 93 3.3k
Pinuccia Faviana 1.0k 1.0× 497 0.7× 956 1.6× 305 0.5× 253 0.5× 85 3.4k
Antonio Gil‐Moreno 808 0.8× 524 0.8× 1.4k 2.2× 656 1.1× 557 1.1× 212 5.1k
Michael Krainer 1.5k 1.4× 477 0.7× 1.4k 2.4× 767 1.3× 329 0.6× 106 3.5k
J. S. Lanchbury 647 0.6× 371 0.5× 723 1.2× 637 1.1× 309 0.6× 41 2.4k
Austin Miller 2.2k 2.0× 936 1.3× 947 1.6× 1.8k 3.1× 310 0.6× 136 4.6k
Evgeny Yakirevich 846 0.8× 614 0.9× 833 1.4× 399 0.7× 283 0.5× 89 2.3k
Anne O’Neill 1.8k 1.7× 822 1.2× 505 0.8× 620 1.1× 225 0.4× 89 3.5k
Jacqueline S. Jeruss 1.3k 1.2× 297 0.4× 979 1.6× 240 0.4× 517 1.0× 106 3.6k
Michel Fabbro 1.1k 1.0× 723 1.0× 658 1.1× 148 0.3× 407 0.8× 187 3.1k
Peter A. Argenta 1.1k 1.0× 507 0.7× 669 1.1× 608 1.0× 257 0.5× 99 3.7k

Countries citing papers authored by Luís Teixeira

Since Specialization
Citations

This map shows the geographic impact of Luís Teixeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Teixeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Teixeira more than expected).

Fields of papers citing papers by Luís Teixeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Teixeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Teixeira. The network helps show where Luís Teixeira may publish in the future.

Co-authorship network of co-authors of Luís Teixeira

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Teixeira. A scholar is included among the top collaborators of Luís Teixeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Teixeira. Luís Teixeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bidard, François‐Clément, Frédérique Berger, Mónica Arnedos, et al.. (2024). Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial.. Journal of Clinical Oncology. 42(16_suppl). TPS1139–TPS1139. 1 indexed citations
2.
Teixeira, Luís, Véronique Dièras, Bruno Crestani, et al.. (2023). Diagnostic et prise en charge de la pneumopathie interstitielle diffuse induite par les anticorps conjugués dans le cancer du sein : avis d’expert. Bulletin du Cancer. 110(9). 937–949. 2 indexed citations
3.
Lamé, Guillaume, Johanna Wassermann, Romain Bey, et al.. (2023). Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study. Cancer Medicine. 12(22). 20918–20929. 4 indexed citations
4.
Bidard, François‐Clément, Nicolas Kiavué, William Jacot, et al.. (2023). Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial. Journal of Clinical Oncology. 42(4). 383–389. 28 indexed citations
5.
Mimoun, Camille, et al.. (2022). Histological Risk Factors for Local Recurrence of Phyllodes Tumors of the Breast. Anticancer Research. 43(1). 143–147. 1 indexed citations
6.
7.
Gounant, V., Valentine Marie Ferré, Charlotte Charpentier, et al.. (2021). Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses. Journal of Thoracic Oncology. 17(2). 239–251. 36 indexed citations
8.
Guillerm, S., E. Bourstyn, L. Quéro, et al.. (2021). Intraoperative Radiotherapy for Breast Cancer in Elderly Women. Clinical Breast Cancer. 22(1). e109–e113. 4 indexed citations
9.
Przanowski, Piotr, Song Lou, Tanmoy Mondal, et al.. (2020). Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer. Cancer Research. 80(21). 4791–4804. 23 indexed citations
10.
Bouaud, Jacques, Sylvia Pelayo, Jean-Baptiste Lamy, et al.. (2020). Implementation of an ontological reasoning to support the guideline-based management of primary breast cancer patients in the DESIREE project. Artificial Intelligence in Medicine. 108. 101922–101922. 15 indexed citations
11.
Groheux, David, Antoine Martineau, Luís Teixeira, et al.. (2017). 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis. Breast Cancer Research. 19(1). 3–3. 63 indexed citations
12.
Quéro, L., S. Guillerm, Sophie Michaud, et al.. (2016). 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment. Radiotherapy and Oncology. 122(1). 11–16. 11 indexed citations
13.
Groheux, David, Alice Sanna, Mohamed Majdoub, et al.. (2015). Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2− Breast Cancer. Journal of Nuclear Medicine. 56(6). 824–831. 43 indexed citations
14.
Goldstein, David, Robert H. El-Maraghi, Pascal Hammel, et al.. (2015). nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. JNCI Journal of the National Cancer Institute. 107(2). dju413–dju413. 504 indexed citations breakdown →
15.
Dupont, Axelle, Luís Teixeira, Raphaël Porcher, et al.. (2015). Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women. The Breast. 25. 51–56. 5 indexed citations
16.
Ezzalfani, Monia, Audrey Emmanuelle Dugué, Caroline Mollévi, et al.. (2015). Le rôle des cohortes d’expansion dans les essais de phase I en cancérologie : des recommandations du HUB phase I. Bulletin du Cancer. 102(1). 73–82. 4 indexed citations
17.
18.
Teixeira, Luís, Fabien Guimiot, Catherine Dodé, et al.. (2010). Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. Journal of Clinical Investigation. 120(10). 3668–3672. 68 indexed citations
19.
Teixeira, Luís, Luc Mouthon, Alfred Mahr, et al.. (2007). Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Annals of the Rheumatic Diseases. 67(1). 110–116. 148 indexed citations
20.
Teixeira, Luís, et al.. (2005). Medicamentos e Alimentação na Prevenção do Câncer de Mama. 16. 15–21.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pinuccia Faviana Breakdown of academic impact, for papers by Antonio Gil‐Moreno Breakdown of academic impact, for papers by Michael Krainer Breakdown of academic impact, for papers by J. S. Lanchbury Breakdown of academic impact, for papers by Austin Miller Breakdown of academic impact, for papers by Evgeny Yakirevich Breakdown of academic impact, for papers by Anne O’Neill Breakdown of academic impact, for papers by Jacqueline S. Jeruss Breakdown of academic impact, for papers by Michel Fabbro Breakdown of academic impact, for papers by Peter A. Argenta
Rankless by CCL
2026